Profile picture

Professor Philip Barter

University of New South Wales Sydney, Sydney (Australia)
Membership: FESC Member
Follow
Logo ESC

Contributor content

PCSK9 inhibition: science, outcomes and guidance (EBAC Accredited)
Session
PCSK9 inhibition: science, outcomes and guidance (EBAC Accredited)
25 August 2018
Read more
State-of-the-art lipid treatment in coronary patients in 2017
Session
State-of-the-art lipid treatment in coronary patients in 2017
29 August 2017
Read more

ESC 365 is supported by

novartis Explore sponsored resources